ClinVar Miner

Submissions for variant NM_054012.4(ASS1):c.1069C>T (p.Gln357Ter) (rs756859126)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000633522 SCV000754761 pathogenic Citrullinemia type I 2018-11-05 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Gln357*) in the ASS1 gene. It is expected to result in an absent or disrupted protein product. This variant is present in population databases (rs756859126, ExAC 0.01%). This variant has been reported in a family with a child affected with the classical neonatal form of citrullinemia (PMID: 24889030). Loss-of-function variants in ASS1 are known to be pathogenic (PMID: 18473344, 19006241). For these reasons, this variant has been classified as Pathogenic.
Counsyl RCV000633522 SCV000799753 likely pathogenic Citrullinemia type I 2018-05-03 criteria provided, single submitter clinical testing
ARUP Laboratories, Molecular Genetics and Genomics,ARUP Laboratories RCV000757010 SCV000885031 likely pathogenic not provided 2017-07-30 criteria provided, single submitter clinical testing The c.1069C>T variant (rs756859126) has been previously reported in an unaffected carrier included in a study of pregnancies at risk for citrullinemia; however, the tested fetus was found not to carry any pathogenic variant and did not have biochemical findings consistent with citrullinemia (Miller 2014). Nonetheless, the c.1069C>T variant introduces an early termination codon into exon 14 (out of 16) in the ASS1 gene and is expected to result in a truncated or absent protein product. Consistent with a heterozygous carrier frequency, this variant is listed in the Genome Aggregation Database (gnomAD) browser with an overall frequency of 0.0004% (identified in 1 out of 245,770 chromosomes). Taken together, this variant is considered likely pathogenic.
Fulgent Genetics,Fulgent Genetics RCV000633522 SCV000893799 pathogenic Citrullinemia type I 2018-10-31 criteria provided, single submitter clinical testing
Baylor Genetics RCV000633522 SCV001163601 pathogenic Citrullinemia type I criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.